You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國抗體-B(03681.HK)中期虧損擴大至1.14億元
格隆匯 08-23 21:58

格隆匯8月23日丨中國抗體-B(03681.HK)發佈公吿,截至2021年6月30日止六個月,公司其他收入及收益1274.5萬元人民幣,上年同期為1866萬元,期內虧損由上年同期的人民幣8080萬元增加至1.14億元。

虧損擴大主要由於(i)研究與開發的商務拓展成本增加約人民幣4220萬元;(ii)其他收入及收益減少約人民幣600萬元(主要因所確認的計入損益的金融資產未變現公平值收益減少所致);及被(iii)行政開支減少約人民幣1710萬元所抵銷,主要因報吿期內並無確認公司受限制股份單位計劃項下的非現金以股份為基礎付款(2020年:人民幣3490萬元)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account